Immunome Inc.(IMNM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IMNM Immunome Inc.

Market Closed 12-19 16:00:00 EST

21.44

+1.49

+7.47%

盘后21.58

+0.14+0.65%

19:30 EST

High21.99	Low20.18	Vol7.34M
Open20.71	D1 Closing19.95	Amplitude9.09%
Mkt Cap2.37B	Tradable Cap2.01B	Total Shares110.34M
T/O156.08M	T/O Rate7.83%	Tradable Shares93.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IMNM","market":"US","secType":"STK","nameCN":"Immunome Inc.","latestPrice":21.44,"timestamp":1766178000000,"preClose":19.95,"halted":0,"volume":7344319,"hourTrading":{"tag":"盘后","latestPrice":21.5787,"preClose":21.44,"latestTime":"19:30 EST","volume":1116004,"amount":23927712.0918,"timestamp":1766190614886},"delay":0,"floatShares":93799100,"shares":110335277,"eps":-2.810829,"marketStatus":"Market Closed","change":1.49,"latestTime":"12-19 16:00:00 EST","open":20.71,"high":21.99,"low":20.1773,"amount":156076554.038589,"amplitude":0.090862,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.810829,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"listingDate":1601611200000,"exchange":"NASDAQ","adjPreClose":19.95,"preHourTrading":{"tag":"盘前","latestPrice":20.51,"preClose":19.95,"latestTime":"09:28 EST","volume":18356,"amount":377985.760776,"timestamp":1766154526025},"postHourTrading":{"tag":"盘后","latestPrice":21.5787,"preClose":21.44,"latestTime":"19:30 EST","volume":1116004,"amount":23927712.0918,"timestamp":1766190614886},"volumeRatio":1.139764,"impliedVol":0.9637,"impliedVolPercentile":0.508},"requestUrl":"/m/hq/s/IMNM/tweets","defaultTab":"tweets","newsList":[{"id":"2592505182","title":"Immunome CEO Clay B. Siegall Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592505182","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592505182?lang=en_us&edition=fundamental","pubTime":"2025-12-19 06:04","pubTimestamp":1766095471,"startTime":"0","endTime":"0","summary":"Clay B. Siegall, President and CEO of Immunome Inc., reported the acquisition of common shares of Immunome Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9qSGz5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Immunome CEO Clay B. Siegall Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4139","BK4563"],"gpt_icon":0},{"id":"2592091186","title":"BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2592091186","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592091186?lang=en_us&edition=fundamental","pubTime":"2025-12-17 23:40","pubTimestamp":1765986030,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Robinhood Markets, Cannabis stocksEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ne","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN14O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSKY","CNX","WMB","GIS","IMNM","FDX","XENE","MCK","NEO","HUT","SCCO","JBL","KYMR","VSCO","FTNT","ABM","COR","WAT","XOM","VOR","LNG","FISI","COUR","NFE","PANW","CYTK","HL","NWBI","DHR","NEM","NUE","WSBC","CVS","HOOD","COP","KYTX","TXRH","VERU","FCX","AVTR","APOG","SPOT","TPL","CVX","FCF","ALB"],"gpt_icon":1},{"id":"2592913067","title":"BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas Roadhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592913067?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:14","pubTimestamp":1765980847,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Jabil, Texas Pacific Land, Texas RoadhouseEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN0N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCCO","VSCO","FTNT","ABM","KOD","HL","XENE","FDX","JBL","NUE","VOR","TE","TPL","VERU","AIR","CDE","CVS","STLD","COR","FISI","USAW.SI","NEO","PANW","UDMY","APOG","ALB","FCX","MCK","COUR","AVTR","CYTK","WAT","IMNM","LU2750360641.GBP","PSKY","WSBC","LU2063271972.USD","NWBI","FCF","HUT","KYMR","NEM","TXRH","GIS","DHR"],"gpt_icon":1},{"id":"2592699095","title":"BUZZ-Immunome slips after $400 mln stock sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2592699095","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592699095?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:00","pubTimestamp":1765976414,"startTime":"0","endTime":"0","summary":"** Shares of biotech co Immunome IMNM.O down 3.5% premarket at $22.65 after $400 mln follow-on priced. ** Bothell, Washington-based IMNM late Tues announced selling ~18.6 mln shares at $21.50, an 8.4% discount to last sale. IMNM shares jumped nearly 16% on Mon after co said its experimental drug, varegacestat, met main goal in late-stage study for patients with desmoid tumors. ** After the bell Mon, co launched $400 mln offering. IMNM shares added another 3.7% on Tues. ** Co plans to use net offering proceeds to fund potential commercial launch of varegacestat, continued commercial development and manufacturing scale-up for varegacestat, continued clinical and preclinical development of other pipeline assets, among other uses, per the offering prospectus. ** Leerink, JP Morgan, TD Cowen, Goldman and Guggenheim are joint bookrunners. ** Stephens analyst Melissa Roberts says in note that IMNM's capital raise qualifies for \"immediate adjustment in market indexes\", and estimates passive de","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN0XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350171.SGD","LU0203347892.USD","IE00BBT3K403.USD","LU2357305700.SGD","LU0234572021.USD","BK4139","LU0048584097.USD","LU1548497426.USD","LU1988902786.USD","IMNM","IE0034235295.USD","LU1670628061.USD","LU0787776722.HKD","LU1914381329.SGD","LU2552382058.USD","LU0964807845.USD","LU1894683348.USD","LU2237443978.SGD","LU0208291251.USD","LU1162221912.USD","LU1084165304.USD","LU1720051017.SGD","LU0496365809.HKD","LU0971096721.USD","IE00BHPRN162.USD","IE00BDRTCR15.USD","LU2756315318.SGD","IE00BKDWB100.SGD","LU2213496289.HKD","LU0320765489.SGD","LU1366192091.USD","LU2242649171.HKD","LU0640476718.USD","LU2505996681.GBP","LU0211331839.USD","LU0943347566.SGD","BK4207","IE00B775SV38.USD","IE00BFXG1179.USD","LU2430703095.HKD","LU1720051108.HKD","LU0106831901.USD","IE00BZ1G4Q59.USD","IE0034235303.USD","LU1668664300.SGD","LU0070302665.USD","LU0942090050.USD","LU0006306889.USD","LU2381873111.SGD","BK4585"],"gpt_icon":0},{"id":"2592497952","title":"Immunome Announces Pricing Of Public Offering Of 18,625,000 Shares At $21.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2592497952","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592497952?lang=en_us&edition=fundamental","pubTime":"2025-12-17 10:15","pubTimestamp":1765937706,"startTime":"0","endTime":"0","summary":"Dec 16 (Reuters) - Immunome Inc ::*IMMUNOME ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK*IMMUNOME INC - PRICES PUBLIC OFFERING OF 18,625,000 SHARES AT $21.50 EACH  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 17-DEC-202501:16:00.07 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nRSD7hpQvs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4139","BK4563"],"gpt_icon":0},{"id":"2592173951","title":"Immunome Inc - Prices Public Offering of 18,625,000 Shares at $21.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2592173951","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592173951?lang=en_us&edition=fundamental","pubTime":"2025-12-17 09:16","pubTimestamp":1765934160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA6NBPV3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","IMNM"],"gpt_icon":0},{"id":"2592939749","title":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2592939749","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592939749?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:43","pubTimestamp":1765907029,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawnAn alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA1LWBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLAY","ONCY","BK4505","PRLD","IMNM","BK4139","BK4563","CNTX","BK4007"],"gpt_icon":0},{"id":"2592939613","title":"Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2592939613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592939613?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:18","pubTimestamp":1765905480,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA1LWBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMNM","BK4563","CNTX","BK4505","BK4139","ONCY","PRLD","RLAY","BK4007"],"gpt_icon":0},{"id":"2591987004","title":"Immunome Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2591987004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591987004?lang=en_us&edition=fundamental","pubTime":"2025-12-16 21:58","pubTimestamp":1765893480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMNM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 16, 2025 08:58 ET (13:58 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4563","BK4139"],"gpt_icon":0},{"id":"2591622377","title":"Immunome Inc - Offering $400 Mln of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591622377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591622377?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:46","pubTimestamp":1765835187,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMNM","BK4563","BK4139"],"gpt_icon":0},{"id":"2591624985","title":"BUZZ-Immunome dips after launching $400 mln stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624985","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624985?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:21","pubTimestamp":1765833665,"startTime":"0","endTime":"0","summary":"** Shares of biotech co Immunome IMNM.O fall 2% post-market to $22.19 as it seeks equity. ** Bothell, Washington-based IMNM commences $400 mln stock offering. ** IMNM shares closed up 15.7% at $22.64 on Mon after co said its experimental drug, varegacestat, met main goal in late-stage study for patients with a rare type of tumor. ** Leerink, J.P. Morgan, TD Cowen, Goldman and Guggenheim are joint bookrunners for the offering. ** With ~91.7 mln shares outstanding, co has ~$2.1 bln market cap** Through Mon, shares up 113% YTD. ** All 13 analysts rate shares \"strong buy\" or \"buy\"; median PT of $32 up from $22 a month ago, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IMNM","BK4563"],"gpt_icon":0},{"id":"2591624674","title":"Immunome Plans $400 Million Public Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624674","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624674?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:20","pubTimestamp":1765833635,"startTime":"0","endTime":"0","summary":"Immunome  said late Monday it intends to launch an underwritten public offering of $400 million of common stock.The underwriters will have a 30-day option to purchase up to $60 million in additional shares.The company said there is no guarantee the offering will be completed or what its final size or terms may be.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IMNM","BK4563"],"gpt_icon":0},{"id":"2591237621","title":"Immunome Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2591237621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591237621?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:01","pubTimestamp":1765832460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA4SFR9W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","BK4139","IMNM"],"gpt_icon":0},{"id":"2591212426","title":"Immunome Inc - to Commence $400 Mln Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2591212426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591212426?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:01","pubTimestamp":1765832460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA4SFR9W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","IMNM"],"gpt_icon":0},{"id":"2591134626","title":"BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2591134626","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591134626?lang=en_us&edition=fundamental","pubTime":"2025-12-16 02:44","pubTimestamp":1765824246,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Brystol Myers, NvidiaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://refi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL4N3XL10S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBL","DG","NVIW.SI","CDE","CPB","FCX","NCLH","LNG","FMC","ZTS","INGM","MOS","CNX","NVDA","LRCX","NOW","NVDS.UK","SNVD.UK","AMAT","KLAC","TXN","VNDA","BMY","HL","ENTG","LAZR","3NVD.UK","IMNM","FAST","CRBG","APD","CVX","KYTX","APA","NVDU","ALB","NEM","NVDX","TPL","LYB","MIST","SPOT","SCCO","XOM"],"gpt_icon":1},{"id":"2591625183","title":"Why Is Immunome Stock Soaring Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591625183","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591625183?lang=en_us&edition=fundamental","pubTime":"2025-12-16 01:12","pubTimestamp":1765818720,"startTime":"0","endTime":"0","summary":"Immunome stock surges after positive results from Phase 3 trial for desmoid tumors, meeting all key endpoints.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/15/Portrait-Of-A-Multiethnic-Student-Workin.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/15/Portrait-Of-A-Multiethnic-Student-Workin.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49399557/why-is-immunome-stock-soaring-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49399557/why-is-immunome-stock-soaring-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","BK4563","IMNM","ORR"],"gpt_icon":0},{"id":"2591628355","title":"Wedbush Adjusts Immunome Price Target to $31 From $21, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628355","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628355?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:58","pubTimestamp":1765814300,"startTime":"0","endTime":"0","summary":"Immunome (IMNM) has an average rating of Buy and mean price target of $25.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMNM","BK4563","BK4139"],"gpt_icon":0},{"id":"2591762833","title":"Immunome Up Over 24%, on Pace for Record Percent Increase -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2591762833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591762833?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:57","pubTimestamp":1765814220,"startTime":"0","endTime":"0","summary":"Immunome, Inc.  is currently at $24.36, up $4.79 or 24.48%. --Would be highest close since March 28, 2024, when it closed at $24.68. --On pace for largest percent increase since Feb. 6, 2024, when it rose 36.91%. --Currently up two consecutive days; up 24.99% over this period. --Down 43.66% from its all-time closing high of $43.24 on Feb. 24, 2021. --Up 95.82% from 52 weeks ago , when it closed at $12.44. --Up 338.13% from its 52-week closing low of $5.56 on April 8, 2025. --Traded as high as $25.30; highest intraday level since March 28, 2024, when it hit $25.75. --Up 29.28% at today's intraday high; largest intraday percent increase since Feb. 6, 2024, when it rose as much as 37.14%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","IMNM"],"gpt_icon":0},{"id":"2591628816","title":"BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, Zillow","url":"https://stock-news.laohu8.com/highlight/detail?id=2591628816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591628816?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:53","pubTimestamp":1765814010,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Vanda Pharma, Tesla, ZillowEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL0UY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995401.HKD","SCCO","NCLH","AMAT","LU0648000940.SGD","APD","LNG","LU0630314457.HKD","MIST","LU1923622614.USD","FAST","LU0654597011.USD","LU0072463663.USD","LU1223083913.SGD","ZTS","FCX","VNDA","INGM","LYB","LRCX","LU1720051108.HKD","KLAC","DG","NOW","TSYW.SI","HL","CDE","CRBG","JBL","IE0034235303.USD","LU1989773731.SGD","NEM","FMC","LU0053666078.USD","LU0889565833.HKD","LU1823568750.SGD","IMNM","CNX","LU0353189763.USD","KYTX","LU0048573561.USD","LU1861214812.USD","LU1992135399.USD","ALB","LU2357125470.USD"],"gpt_icon":1},{"id":"2591774644","title":"BUZZ-U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNow","url":"https://stock-news.laohu8.com/highlight/detail?id=2591774644","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591774644?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:18","pubTimestamp":1765808318,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Micron Technology, Carvana, ServiceNowEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL6N3XL0MU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","HL","LYB","NEM","LU1778281490.HKD","IE00BZ9MQY76.HKD","IMNM","KYTX","ZTS","CVNA","BK4551","FMC","LU0011850046.USD","SCCO","LU1223082196.USD","BK4550","IE0034235303.USD","LU0256863811.USD","NCLH","MIST","LU0640476718.USD","CDE","DG","LU1551013342.USD","KLAC","LRCX","LU1153585028.USD","FCX","FAST","BK4564","NVMI","IE00B7SZLL34.SGD","LU2360106780.USD","IE0009356076.USD","AU","LU2125909916.SGD","LU2237443382.USD","IE00BJJMRY28.SGD","LU2290526834.HKD","AMAT","LU2931357623.SGD","MU","APD","NOW","LU1989763005.USD","CRBG","LU0265550946.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.immunome.com","stockEarnings":[{"period":"1week","weight":0.0956},{"period":"1month","weight":0.212},{"period":"3month","weight":1.2833},{"period":"6month","weight":1.4503},{"period":"1year","weight":0.935},{"period":"ytd","weight":1.0188}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.434652},{"month":2,"riseRate":0.4,"avgChangeRate":0.326996},{"month":3,"riseRate":0.4,"avgChangeRate":-0.090619},{"month":4,"riseRate":0.2,"avgChangeRate":-0.143676},{"month":5,"riseRate":0.6,"avgChangeRate":-0.004931},{"month":6,"riseRate":0.4,"avgChangeRate":0.006649},{"month":7,"riseRate":0.6,"avgChangeRate":0.091554},{"month":8,"riseRate":0.2,"avgChangeRate":0.026473},{"month":9,"riseRate":0.6,"avgChangeRate":0.199621},{"month":10,"riseRate":0.4,"avgChangeRate":0.031075},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.006249},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.093132}],"exchange":"NASDAQ","name":"Immunome Inc.","nameEN":"Immunome Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunome Inc.(IMNM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Immunome Inc.(IMNM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Immunome Inc.,IMNM,Immunome Inc.股票,Immunome Inc.股票老虎,Immunome Inc.股票老虎国际,Immunome Inc.行情,Immunome Inc.股票行情,Immunome Inc.股价,Immunome Inc.股市,Immunome Inc.股票价格,Immunome Inc.股票交易,Immunome Inc.股票购买,Immunome Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunome Inc.(IMNM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Immunome Inc.(IMNM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction